You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 29, 2024

Litigation Details for FWK Holdings LLC v. Shire PLC (Direct Purchaser Antitrust Class Action Complaint) (D. Mass. 2016)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in FWK Holdings LLC v. Shire PLC (Direct Purchaser Antitrust Class Action Complaint)
The small molecule drug covered by the patents cited in this case is ⤷  Sign Up .

Details for FWK Holdings LLC v. Shire PLC (Direct Purchaser Antitrust Class Action Complaint) (D. Mass. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-12-30 1 Orange Book U.S. Patent Nos. 5,854,290 (the ’290 patent), 6,287,599 (the ’599 patent), and 6,811,794 …approval. The ’290 patent is a method-of-use patent, and the ’599 and ’794 patents cover the coating …manufacturer to provide an honest appraisal of its patent’s (or patents’) validity and applicability, as the FDA…authority to analyze the manufacturer’s patent(s). By listing patents in the Orange Book, the FDA is merely… validity and/or enforceability of patents or invent around patents, the Hatch- Waxman Amendments grant External link to document
2019-10-29 349 Attached as Exhibit 293 is patent trial exhibit PTX1, U.S. Patent Number 6,287,599 dated September 11, 2001…75. Attached as Exhibit 186 is U.S. Patent Number 6,287,599 dated September 11, 2001, which was produced… Attached as Exhibit 285 is patent trial exhibit DTX 226, European Patent Application 0266707, Sustained…Attached as Exhibit 291 is patent trial exhibit DTX 229, International Patent Application WO 99/66904,… Attached as Exhibit 292 is patent trial exhibit DTX 183, U.S. Patent Number 5,854,290 dated December External link to document
2017-10-10 92 three patents in the Orange Book as covering Intuniv: U.S. Patents Nos. 5,854,290 (the ‘290 patent), 6,…6,287,599 (the ‘599 patent), and 6,811,794 (the ‘794 patent) (collectively, “the Intuniv Patents”).3 Id. ¶ 99…in which a patent holder, who originally brought suit for patent infringement, pays a patent challenger… any patents that claim the new drug, and, if approved, the manufacturer must list these patents in the…but instead consist of one method-of-use patent and two patents covering the coating that enables a gradual External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.